2 Day Seminar: Latin America – Regulatory Compliance Requirements for Life Science Products (New Orleans, LA, USA – May 31st-June 1st, 2018)

April 19, 2018 | By forimmediaterele | Filed in: Press Releases.

Travel & Tourism Industry release:

This two-day comprehensive course will cover topics ranging from pre-clinical and clinical requirements through product registration, amendments and renewals across Pharmaceuticals, Biologics, Medical Devices and Combination Products. The course will address the structure of the regulatory agencies in Latin America and discuss local cultural nuances to help you be successful in working with the regulators.

This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in Latin America. The primary countries covered will include: Argentina, Brazil and Mexico. Other countries such as Chile, Costa Rica, Dominican Republic, Panama, Peru and Venezuela will be discussed. The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in Latin America. Content will include descriptions of the methods by which regulators in the corresponding agencies process filings and registrations and what is expected in the authorization and dossier maintenance of the wide array of licensed products.

The current regulatory climate in Latin America is discussed in detail and several examples will be provided to illustrate effective compliance procedures and techniques. Common issues that have caused difficulties for Life Sciences firms in the region are outlined. Course content will explain how Latin America interacts with and utilizes ICH standards and how they relate with other National Healthcare Authorities. Additionally, participants will learn how personnel can best address the conflicts, which arise and the best course for resolution.


Day One (8:30 AM – 4:30 PM)

Registration Process: 8:30 AM – 9:00 AM

Session Start Time: 9:00 AM

LA Overview

LA Markets

Harmonization efforts

Understanding the Regulatory ProcessRegulatory Overview (gov’t offices, organization, contact info)

  • Brazil ANVISA
  • Mexico – COFEPRIS
  • Argentina – ANMAT

Country Establishment

  • Clinical Trials
  • Clinical Trial Start-up
  • Clinical Trial Application
  • IND’s
  • Reporting
  • GCP

Scientific advice

Stability studies

  • Pharmaceuticals
  • Marketing Authorizations/Registrations
  • Registration requirements
  • Registration documentation/CTD
  • Summary of Product Characteristics
  • Package insert
  • Labeling
  • Pharmacovigilance/Post-marketing
  • Amendments/Variations/Changes/Renewals
  • Fees

Submission Process

Paper filings

Electronic filings

Day Two (8:30 AM – 4:30 PM)

Generics & Bioequivalence


Compassionate use

Orphan drugs

  • Medical Devices
  • Device Classification
  • Testing Standards
  • Registrations
  • Amendments/Variations/Renewals
  • Cost build-up model
  • Fees
  • Post-marketing

Combination products


Import/Export procedures

Tax exemptions


Comparing & Contrasting LA and US

Challenges in Latin America

Influencing the Regulatory Process

Conclusions & summary

For more information about this conference visit https://www.researchandmarkets.com/research/ww978r/2_day_seminar?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/2-day-seminar-latin-america—regulatory-compliance-requirements-for-life-science-products-new-orleans-la-usa—may-31st-june-1st-2018-300633023.html

SOURCE Research and Markets

Related Links


Click here to read the full release with contact information on PR Newswire. Some releases are not in English.

To post and circulate your own press release on FIR and the eTN Network  please click here 


Comments are closed here.